SHL Telemedicine Ltd (SHLT) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care

DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine

David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the...

SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine...

SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test

Users in Israel will be able for the first time in the world to perform an at-home Biomarker blood test guided by SHL’s medical team, following...

SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch

A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service now fully available in the US. SHL Telemedicine...